Published in Curr Pharm Des on January 01, 2002
Complete genome sequence of the industrial bacterium Bacillus licheniformis and comparisons with closely related Bacillus species. Genome Biol (2004) 2.41
Discovery of unique lanthionine synthetases reveals new mechanistic and evolutionary insights. PLoS Biol (2010) 1.74
Identification of a novel two-peptide lantibiotic, lichenicidin, following rational genome mining for LanM proteins. Appl Environ Microbiol (2009) 1.68
Bacteriocin diversity in Streptococcus and Enterococcus. J Bacteriol (2006) 1.57
Genome mining and genetic analysis of cypemycin biosynthesis reveal an unusual class of posttranslationally modified peptides. Proc Natl Acad Sci U S A (2010) 1.52
Evolution of lanthipeptide synthetases. Proc Natl Acad Sci U S A (2012) 1.44
Mechanistic investigations of the dehydration reaction of lacticin 481 synthetase using site-directed mutagenesis. Biochemistry (2007) 1.36
DAMPD: a manually curated antimicrobial peptide database. Nucleic Acids Res (2011) 1.24
Mutants of the zinc ligands of lacticin 481 synthetase retain dehydration activity but have impaired cyclization activity. Biochemistry (2007) 1.22
The dual role of bacteriocins as anti- and probiotics. Appl Microbiol Biotechnol (2008) 1.22
Lantibiotics as probes for phosphatidylethanolamine. Amino Acids (2009) 1.20
In vitro reconstitution and substrate specificity of a lantibiotic protease. Biochemistry (2008) 1.16
Nine post-translational modifications during the biosynthesis of cinnamycin. J Am Chem Soc (2011) 1.15
Genome mining for radical SAM protein determinants reveals multiple sactibiotic-like gene clusters. PLoS One (2011) 1.01
The lantibiotic mersacidin is an autoinducing peptide. Appl Environ Microbiol (2006) 0.97
Biosynthesis and regulation of grisemycin, a new member of the linaridin family of ribosomally synthesized peptides produced by Streptomyces griseus IFO 13350. J Bacteriol (2011) 0.92
Manipulation of charged residues within the two-peptide lantibiotic lacticin 3147. Microb Biotechnol (2009) 0.86
Bioengineering Lantibiotics for Therapeutic Success. Front Microbiol (2015) 0.86
Relatedness between the two-component lantibiotics lacticin 3147 and staphylococcin C55 based on structure, genetics and biological activity. BMC Microbiol (2007) 0.84
Investigating the importance of charged residues in lantibiotics. Bioeng Bugs (2011) 0.82
Lantibiotic transporter requires cooperative functioning of the peptidase domain and the ATP binding domain. J Biol Chem (2011) 0.80
Identification of a nisI promoter within the nisABCTIP operon that may enable establishment of nisin immunity prior to induction of the operon via signal transduction. J Bacteriol (2006) 0.80
Insights into Lantibiotic Immunity Provided by Bioengineering of LtnI. Antimicrob Agents Chemother (2012) 0.78
Synthesis of pdCpAs and transfer RNAs activated with thiothreonine and derivatives. Bioorg Med Chem (2012) 0.78
Antimicrobial nisin acts against saliva derived multi-species biofilms without cytotoxicity to human oral cells. Front Microbiol (2015) 0.76
Lanthipeptides: chemical synthesis versus in vivo biosynthesis as tools for pharmaceutical production. Microb Cell Fact (2016) 0.76
Mechanistic Understanding of Lanthipeptide Biosynthetic Enzymes. Chem Rev (2017) 0.75
Antimicrobial Peptides as Potential Alternatives to Antibiotics in Food Animal Industry. Int J Mol Sci (2016) 0.75
Oxidative stress induced in E. coli by the human antimicrobial peptide LL-37. PLoS Pathog (2017) 0.75
Matrix-assisted laser desorption ionization-time of flight mass spectrometry for fast and reliable identification of clinical yeast isolates. J Clin Microbiol (2009) 3.45
Lantibiotics: mode of action, biosynthesis and bioengineering. Curr Pharm Biotechnol (2009) 2.56
The lipopeptide antibiotic Friulimicin B inhibits cell wall biosynthesis through complex formation with bactoprenol phosphate. Antimicrob Agents Chemother (2009) 1.38
Naturally processed dermcidin-derived peptides do not permeabilize bacterial membranes and kill microorganisms irrespective of their charge. Antimicrob Agents Chemother (2006) 1.18
In vitro activity and mode of action of diastereomeric antimicrobial peptides against bacterial clinical isolates. J Antimicrob Chemother (2004) 1.11
Analysis of in vitro activities and modes of action of synthetic antimicrobial peptides derived from an alpha-helical 'sequence template'. J Antimicrob Chemother (2008) 1.08
Differential expression of alpha- and beta-defensins in human peripheral blood. Eur J Clin Invest (2003) 0.99
Influence of Ca(2+) ions on the activity of lantibiotics containing a mersacidin-like lipid II binding motif. Appl Environ Microbiol (2009) 0.80